174 related articles for article (PubMed ID: 12028215)
1. The impact of symptom severity on the cost of Alzheimer's disease.
Small GW; McDonnell DD; Brooks RL; Papadopoulos G
J Am Geriatr Soc; 2002 Feb; 50(2):321-7. PubMed ID: 12028215
[TBL] [Abstract][Full Text] [Related]
2. Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.
Tahami Monfared AA; Khachatryan A; Hummel N; Kopiec A; Martinez M; Zhang R; Zhang Q
J Alzheimers Dis; 2024; 99(1):191-206. PubMed ID: 38640156
[TBL] [Abstract][Full Text] [Related]
3. The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients.
Beeri MS; Werner P; Davidson M; Noy S
Int J Geriatr Psychiatry; 2002 May; 17(5):403-8. PubMed ID: 11994927
[TBL] [Abstract][Full Text] [Related]
4. Measuring the Caregiver Burden of Caring for Community-Residing People with Alzheimer's Disease.
Yu H; Wang X; He R; Liang R; Zhou L
PLoS One; 2015; 10(7):e0132168. PubMed ID: 26154626
[TBL] [Abstract][Full Text] [Related]
5. Caregivers' Sense of Coherence: Implications on Direct and Indirect Costs of Dementia Care.
Turró-Garriga O; Viñas-Díez V; Conde-Sala JL; Calvó-Perxas L; Cullell-Juncà M; Mas-Vall-Llosera G; Flaqué M; Turon-Estrada A; Juvinyà-Canal D; Mioshi E; Garre-Olmo J
J Alzheimers Dis; 2020; 78(1):117-126. PubMed ID: 32925037
[TBL] [Abstract][Full Text] [Related]
6. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease.
Bergvall N; Brinck P; Eek D; Gustavsson A; Wimo A; Winblad B; Jönsson L
Int Psychogeriatr; 2011 Feb; 23(1):73-85. PubMed ID: 20619068
[TBL] [Abstract][Full Text] [Related]
8. What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.
Reed C; Happich M; Argimon JM; Haro JM; Wimo A; Bruno G; Dodel R; Jones RW; Vellas B; Belger M
J Alzheimers Dis; 2017; 57(3):797-812. PubMed ID: 28304285
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community.
Zhu CW; Scarmeas N; Torgan R; Albert M; Brandt J; Blacker D; Sano M; Stern Y
J Am Geriatr Soc; 2006 Oct; 54(10):1596-602. PubMed ID: 17038080
[TBL] [Abstract][Full Text] [Related]
10. Cost of Alzheimer's disease in a developing country setting.
Zencir M; Kuzu N; Beşer NG; Ergin A; Catak B; Sahiner T
Int J Geriatr Psychiatry; 2005 Jul; 20(7):616-22. PubMed ID: 16021668
[TBL] [Abstract][Full Text] [Related]
11. Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.
Robinson RL; Rentz DM; Andrews JS; Zagar A; Kim Y; Bruemmer V; Schwartz RL; Ye W; Fillit HM
J Alzheimers Dis; 2020; 75(2):437-450. PubMed ID: 32250304
[TBL] [Abstract][Full Text] [Related]
12. Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain.
Darbà J; Kaskens L; Lacey L
Eur J Health Econ; 2015 Nov; 16(8):895-905. PubMed ID: 25348897
[TBL] [Abstract][Full Text] [Related]
13. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.
Olazarán J; Agüera-Ortiz L; Argimón JM; Reed C; Ciudad A; Andrade P; Dilla T
Int Psychogeriatr; 2017 Dec; 29(12):2081-2093. PubMed ID: 28720158
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.
Zhu CW; Scarmeas N; Torgan R; Albert M; Brandt J; Blacker D; Sano M; Stern Y
Neurology; 2006 Sep; 67(6):998-1005. PubMed ID: 16914696
[TBL] [Abstract][Full Text] [Related]
15. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect cost of managing alzheimer's disease and related dementias in the United States.
Deb A; Thornton JD; Sambamoorthi U; Innes K
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):189-202. PubMed ID: 28351177
[TBL] [Abstract][Full Text] [Related]
17. The relationship between caregivers' global ratings of Alzheimer's disease patients' quality of life, disease severity, and the caregiving experience.
Karlawish JH; Casarett D; Klocinski J; Clark CM
J Am Geriatr Soc; 2001 Aug; 49(8):1066-70. PubMed ID: 11555068
[TBL] [Abstract][Full Text] [Related]
18. National Estimates of Incremental Work Absenteeism Costs Associated With Adult Children of Parents With Alzheimer's Disease and Related Dementias.
Jang S; Chen J
Am J Geriatr Psychiatry; 2024 Aug; 32(8):972-982. PubMed ID: 38604922
[TBL] [Abstract][Full Text] [Related]
19. Informal costs of dementia care: estimates from the National Longitudinal Caregiver Study.
Moore MJ; Zhu CW; Clipp EC
J Gerontol B Psychol Sci Soc Sci; 2001 Jul; 56(4):S219-28. PubMed ID: 11445614
[TBL] [Abstract][Full Text] [Related]
20. Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.
Kahle-Wrobleski K; Fillit H; Kurlander J; Reed C; Belger M
Eur J Health Econ; 2015 Dec; 16(9):995-1004. PubMed ID: 25410743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
